novo nordisk semaglutide fda withdraws application to expand use of weight loss drug FDA Seizes 'Thousands of Doses'

They also had a mean BMI of 35.7 to 38.5, with all of them having a BMI of at least 30 or 27 with a pre-existing condition related to their weight that wasn't type 2 diabetes

Label of vial contains information regarding concentration, active ingredient, batch number, expiry date and storage precautions

Food & Drug Administration (FDA-c)

Folic Acid: Helps the body produce healthy red blood cells

The Phase 3 trial program for Retatrutide includes arms specifically designed to evaluate maintenance dosing strategies, and those results will likely inform how the medical community thinks about long-term management using this compound